Crossing the Chasm – a critical survival risk for young ortho companies.

Scaling sales beyond the Early Adopters could be the most challenging area for ortho startups. Much harder than the technology, the regulatory pathway, the funding, the team, etc. This Chasm wall becomes pivotal threat to ongoing viability of the company. This is especially true today's financial environment, as the Chasm can be wider, because you cannot expect cross the Chasm with more growth capital. This is what I accidentally referred to the article, Easy to Start, Hard to Grow. Then Marc Viscogliosi hit the nail on the head during our BoneChat discussion. Watch below (1 min).

This narrative, inspired by Geoffrey Moore's seminal work "Crossing the Chasm," seeks to contextualize the journey of orthopedic innovations from conception through to mainstream acceptance, emphasizing the unique challenges encountered along this trajectory. The inception of an orthopedic startup is often propelled by the vision to introduce pioneering solutions that revolutionize patient care. These startups typically gain initial traction among Innovator and Early Adopter surgeons, who, driven by a passion for technological advancements and imp...